| MEDIGENE AG NA O.N. |
| Deutschland |
| Gesundheit |
| DE000A40ESG2 / A40ESG |
| MDG1 (Frankfurt) |
| FRA:MDG1, ETR:MDG1, MDG1:GR |
| - |
| https://medigene.de/ |
|
Medigene AG is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer. As a pioneer in the field of T cell-focused therapies, Medigene leverages its deep knowledge in immunology and genetics to de..
>Volltext.. |
| 0.37 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| MEDIGENE |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|